PMB #117, 2801 Centerville Road
1st Floor
Wilmington, DE 19808-1609
United States
877 354 3689
https://eliemtx.com
Secteur(s): Healthcare
Secteur d’activité: Biotechnology
Employés à temps plein: 9
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Dr. Andrew Levin M.D., Ph.D. | Principal Financial Officer & Executive Chairman | 65,39k | S.O. | 1978 |
Dr. Valerie Morisset Ph.D. | Chief Scientific Officer and Executive VP of Research & Development | 1,08M | S.O. | 1970 |
Ms. Emily Pimblett | Chief Accounting Officer | S.O. | S.O. | 1984 |
Ms. Jo Palmer-Phillips Ph.D. | Chief Development Officer | S.O. | S.O. | S.O. |
Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.
L’ISS Governance QualityScore de Eliem Therapeutics, Inc. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..